Linearis Labs Selected for Two Projects Under Terry Fox Research Institute's Digital Health Innovation Fund

QUÉBEC CITY, Sept. 16, 2026 /PRNewswire/ -- Linearis Labs has been selected to receive funding in two of the 14 pan-Canadian project teams announced today by the Terry Fox Research Institute (TFRI) under its Digital Health Innovation Fund, a program led by TFRI's Digital Health & Discovery Platform (DHDP). The 14 funded projects represent a combined investment of $40.9M and bring together 55 partners across Canada to advance AI-driven health data sharing for precision medicine.

In its announcement, TFRI President and Scientific Director Dr. Jim Woodgett said the initiative reflects "research and enterprise coming together to drive innovation." (Full release: www.dhdp.ca)

Linearis Labs' two funded projects are:

Multi-Omics Data to AI Disease Signature Discovery. In association with MRM Proteomics, Simmunome, the Jewish General Hospital/CIUSSS du Centre-Ouest-de-l'Île-de-Montréal, and Nova Scotia Health. The project applies AI to integrated genomic, proteomic, and metabolomic data to predict which treatments are most likely to work for patients with lung, breast, or colorectal cancers.

AI-Enabled Biomarker Discovery and Therapeutic Monitoring in Neurodegenerative Disease. In collaboration with Nanil Therapeutics, the project uses secure, standardized health data and AI to identify biological signals that can improve how neurodegenerative diseases are studied and monitored.

"Cancer and neurodegenerative diseases are complex, and no single type of data can capture them holistically. By combining genomics, proteomics, and TMIC's 1,780 metabolomics GigaKit™ panel with our AI reasoning layer, we can finally see the whole picture of a disease, not just a fragment, so patients can be diagnosed sooner and treated with what actually works for them," said Alexandre Le Bouthillier, CEO, Linearis Labs.

Both projects will draw on the DHDP's federated learning infrastructure, allowing researchers to analyze data across institutions without moving it, preserving privacy while enabling AI-driven discovery and creating new investment opportunities.

More information on funded projects and participating organizations is available at www.dhdp.ca/projects

About Linearis

Linearis, with its tandem Ventures Fund and Laboratory, is pioneering and supporting discoveries to prevent, detect, and cure diseases through direct investments in innovative AI-powered life sciences companies. To learn more about Linearis, visit www.linearis.com

SOURCE Linearis